These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Influenza virus infection as well as immunization with DNA encoding haemagglutinin protein induces potent antibody-dependent phagocytosis (ADP) and monocyte infection-enhancing responses in macaques. Koopman G; Mortier D; Michels S; Hofman S; Fagrouch Z; Remarque EJ; Verschoor EJ; Mooij P; Bogers WMJM J Gen Virol; 2019 May; 100(5):738-751. PubMed ID: 30920368 [TBL] [Abstract][Full Text] [Related]
12. Seasonal influenza vaccine delivered by intradermal microinjection: A randomised controlled safety and immunogenicity trial in adults. Leroux-Roels I; Vets E; Freese R; Seiberling M; Weber F; Salamand C; Leroux-Roels G Vaccine; 2008 Dec; 26(51):6614-9. PubMed ID: 18930093 [TBL] [Abstract][Full Text] [Related]
13. Seasonal Influenza Vaccination of Children Induces Humoral and Cell-Mediated Immunity Beyond the Current Season: Cross-reactivity With Past and Future Strains. Reber AJ; Kim JH; Coleman LA; Spencer SM; Chung JR; Chen J; Gargiullo P; Sundaram ME; Belongia EA; Shay DK; Katz JM; Sambhara S J Infect Dis; 2016 Nov; 214(10):1477-1486. PubMed ID: 27571905 [TBL] [Abstract][Full Text] [Related]
14. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin. Bright RA; Carter DM; Daniluk S; Toapanta FR; Ahmad A; Gavrilov V; Massare M; Pushko P; Mytle N; Rowe T; Smith G; Ross TM Vaccine; 2007 May; 25(19):3871-8. PubMed ID: 17337102 [TBL] [Abstract][Full Text] [Related]
15. Safety and immunogenicity of an AS03-adjuvanted A(H1N1)pmd09 vaccine administered simultaneously or sequentially with a seasonal trivalent vaccine in adults 61 years or older: data from two multicentre randomised trials. Peeters M; Regner S; Vaman T; Devaster JM; Rombo L Vaccine; 2012 Oct; 30(45):6483-91. PubMed ID: 22885014 [TBL] [Abstract][Full Text] [Related]
16. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers. Englund JA; Walter EB; Gbadebo A; Monto AS; Zhu Y; Neuzil KM Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949 [TBL] [Abstract][Full Text] [Related]
17. Immunogenicity and safety of a cell culture-derived inactivated quadrivalent influenza vaccine (NBP607-QIV): A randomized, double-blind, multi-center, phase III clinical trial in adults and elderly subjects. Choi WS; Noh JY; Song JY; Cheong HJ; Wie SH; Lee JS; Lee J; Kim SW; Jeong HW; Jung SI; Kim YS; Woo HJ; Kim KH; Kim H; Kim WJ Hum Vaccin Immunother; 2017 Jul; 13(7):1653-1660. PubMed ID: 28406746 [TBL] [Abstract][Full Text] [Related]
18. Impact of age and pre-existing influenza immune responses in humans receiving split inactivated influenza vaccine on the induction of the breadth of antibodies to influenza A strains. Nuñez IA; Carlock MA; Allen JD; Owino SO; Moehling KK; Nowalk P; Susick M; Diagle K; Sweeney K; Mundle S; Vogel TU; Delagrave S; Ramgopal M; Zimmerman RK; Kleanthous H; Ross TM PLoS One; 2017; 12(11):e0185666. PubMed ID: 29091724 [TBL] [Abstract][Full Text] [Related]
19. Influenza vaccination in children primed with MF59-adjuvanted or non-adjuvanted seasonal influenza vaccine. Vesikari T; Forstén A; Arora A; Tsai T; Clemens R Hum Vaccin Immunother; 2015; 11(8):2102-12. PubMed ID: 26091244 [TBL] [Abstract][Full Text] [Related]
20. Antibody Landscape Analysis following Influenza Vaccination and Natural Infection in Humans with a High-Throughput Multiplex Influenza Antibody Detection Assay. Li ZN; Liu F; Gross FL; Kim L; Ferdinands J; Carney P; Chang J; Stevens J; Tumpey T; Levine MZ mBio; 2021 Feb; 12(1):. PubMed ID: 33531397 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]